Enzymotec wins Israeli phytosterol patent

- Last updated on GMT

Related tags: Denmark, European union, New zealand

Israeli-based lipid specialist, Enzymotec, has been granted a home turf patent for the composition and production of its phytosterol ingredient, Cardiobeat.

The patent follows previous approvals granted in China and New Zealand as well as new dietary ingredient status in the US and novel food approval in the European Union.

Further process and efficacy patents are pending in other international jurisdictions.

CardiaBeat, derived from an omega-3 glyceride matrix, has been shown to reduce the likelihood of cardiovascular disease in clinical trials.

Related news

Show more

Related products

Mediterranean Nutraceutical products

Mediterranean Nutraceutical products

Esserre Pharma | 19-Apr-2022 | Product Brochure

From the best Mediterranean ingredients to effective and safe finished products, Esserre Pharma researches and develops unique formulations.

A premium grade of spirulina

A premium grade of spirulina

Robertet Health & Beauty | 20-Mar-2022 | Technical / White Paper

Robertet and fleur-2-vie joined their expertise to unveil Spiruline Safe®, a premium quality of Spirulina produced through a unique, fully controlled process...

POLARIS LAUNCHES CLEAN TASTE & SMELL DHA VEGAN

POLARIS LAUNCHES CLEAN TASTE & SMELL DHA VEGAN

POLARIS | 02-Feb-2022 | Data Sheet

Polaris introduces its first 100% vegan powder, highly concentrated in DHA, with neutral taste and smell. Perfect for tableting, powder drinks and many...

Related suppliers

Follow us

Products

View more

Webinars